Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Study to Evaluate the Reliability of Electrographic Flow™ (EGF) Mapping Algorithm Technology to Identify Sources of Atrial Fibrillation and Guide Ablation Therapy in Patients With Persistent Atrial Fibrillation
Conditions
Interventions
Electrographic Flow™ guided ablation
Locations
4
Czechia
Nemocnice Na Homolce Hospital
Prague, Czech Republic, Czechia
Practice Clinic Heart And Vessels
Dresden, Saxony Land, Germany
University Heart and Vascular Center Hamburg
Hamburg, Germany
Erasmus Medical Center
Rotterdam, South Holland, Netherlands
Start Date
September 27, 2019
Primary Completion Date
September 27, 2021
Completion Date
September 27, 2021
Last Updated
April 10, 2025
NCT05411614
NCT06445439
NCT04715425
NCT05870306
NCT05993104
NCT05944575
Lead Sponsor
Cortex
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions